IGF2R and COVID-19: Previous research demonstrated that with increasing exposure time to SARS-CoV-2, two receptors, EGFR and IGF2R, which play crucial roles in the RAS signaling pathway, are significantly downregulated in infected human bronchial epithelial cells during the propagating phase of COVID-19 [7].